The Ablatherm HIFU system probe (Photo courtesy of EDAP TMS )
Therapeutic Ultrasound System Ablates Prostate Tissue
|
By HospiMedica International staff writers Posted on 22 Nov 2015 |
|
The Ablatherm HIFU system probe (Photo courtesy of EDAP TMS )
A new high-intensity focused ultrasound (HIFU) system offers an effective option for prostatic tissue ablation with a low occurrence of side effects.
The Ablatherm HIFU system is intended for treating patients with localized prostate cancer (stages T1-T2) who are not surgical candidates due to age or comorbidities, those who prefer an alternative option, or for patients who failed previous radiotherapy (RT) treatment. The system itself consists of a treatment module, a control module, and a probe with both treatment and imaging transducers. After a spinal epidural or general anesthetic (GA) is administered, the patient lies down on his right lateral decubitus and stays in this position throughout the treatment.
The Ablatherm HIFU probe is then introduced in the rectum, and the imaging transducer scans the prostate gland to plan robotic treatment. Once the ablation sequence is finalized, the treatment transducer emits HIFU ultrasound in the prostate gland; at the focal point—where the ultrasound waves are focused—the absorption of the ultrasound emission beam creates a sudden temperature increase, to around 85 °C, which destroys the tissue in the targeted zone. The Ablatherm HIFU system is a product of EDAP TMS (Vaulx-en-Velin, France), and has been approved by the US Food and Drug Administration (FDA).
“This clearance represents a unique opportunity for EDAP and its superior HIFU technology to penetrate the largest prostate market in the world in the same way it has emerged as the leading HIFU technology in Europe,” said Marc Oczachowski, CEO of EDAP TMS. “The pieces are in place to begin deploying Ablatherm devices in the US very quickly, and we look forward to bringing the technology to urologists as well as patients in need.”
HIFU technology is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be ablated, while the surrounding tissue retains as little damage as possible.
Related Links:
EDAP TMS
Link to video
The Ablatherm HIFU system is intended for treating patients with localized prostate cancer (stages T1-T2) who are not surgical candidates due to age or comorbidities, those who prefer an alternative option, or for patients who failed previous radiotherapy (RT) treatment. The system itself consists of a treatment module, a control module, and a probe with both treatment and imaging transducers. After a spinal epidural or general anesthetic (GA) is administered, the patient lies down on his right lateral decubitus and stays in this position throughout the treatment.
The Ablatherm HIFU probe is then introduced in the rectum, and the imaging transducer scans the prostate gland to plan robotic treatment. Once the ablation sequence is finalized, the treatment transducer emits HIFU ultrasound in the prostate gland; at the focal point—where the ultrasound waves are focused—the absorption of the ultrasound emission beam creates a sudden temperature increase, to around 85 °C, which destroys the tissue in the targeted zone. The Ablatherm HIFU system is a product of EDAP TMS (Vaulx-en-Velin, France), and has been approved by the US Food and Drug Administration (FDA).
“This clearance represents a unique opportunity for EDAP and its superior HIFU technology to penetrate the largest prostate market in the world in the same way it has emerged as the leading HIFU technology in Europe,” said Marc Oczachowski, CEO of EDAP TMS. “The pieces are in place to begin deploying Ablatherm devices in the US very quickly, and we look forward to bringing the technology to urologists as well as patients in need.”
HIFU technology is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be ablated, while the surrounding tissue retains as little damage as possible.
Related Links:
EDAP TMS
Link to video
Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Radial Artery Compression Device
TR Band
New
Steam Sterilizer
AMSCO 400 Series
Read the full article by registering today, it's FREE! 
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine. 
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Surgical Techniques News
- Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
- LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
- New Surgical Microscope Offers Precise 3D Imaging Using 48 Tiny Cameras
- First-Of-Its-Kind Drug Illuminates Nerve Tissue for Faster and Safer Surgery
- Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
- New Surgical Technique Safely Removes Giant Nerve Tumors
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
Channels
Critical Care
view channel
Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
For individuals with Type 1 diabetes, hypoglycemia (low blood sugar) presents a life-threatening threat, particularly when glucose levels drop too low, which can result in seizures, coma, or even death.... Read more
New Prostate Screening Device Could Replace Traditional Examination Method
Prostate cancer is a leading health concern, with one in seven men being diagnosed with the disease. Early detection is critical for improving patient outcomes, but traditional diagnostic methods, such... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
